Microchip Technology Crecimiento futuro
Future controles de criterios 5/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Microchip Technology de 31% y 10.6% por año respectivamente. Se prevé que el BPA crezca en un 31.1% al año. Se espera que la rentabilidad financiera sea de 30.3% en 3 años.
Información clave
31.0%
Tasa de crecimiento de los beneficios
31.1%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Semiconductor | 28.2% |
Tasa de crecimiento de los ingresos | 10.6% |
Rentabilidad financiera futura | 30.3% |
Cobertura de analistas | Good |
Última actualización | 19 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Microchip Technology (NASDAQ:MCHP) Will Pay A Larger Dividend Than Last Year At $0.455
Nov 09When Should You Buy Microchip Technology Incorporated (NASDAQ:MCHP)?
Oct 28Momentum Is Gone From Microchip Technology
Oct 22Microchip Technology (NASDAQ:MCHP) Might Have The Makings Of A Multi-Bagger
Oct 01Microchip Technology (NASDAQ:MCHP) Seems To Use Debt Quite Sensibly
Sep 04Microchip Technology's (NASDAQ:MCHP) Dividend Will Be Increased To $0.454
Aug 20Downgrade: Here's How Analysts See Microchip Technology Incorporated (NASDAQ:MCHP) Performing In The Near Term
Aug 08Microchip: Cyclical Recovery Got Delayed, But I Still Think It's Near
Aug 06Microchip Technology (NASDAQ:MCHP) Is Increasing Its Dividend To $0.454
Aug 06Is It Too Late To Consider Buying Microchip Technology Incorporated (NASDAQ:MCHP)?
Jul 28There's Reason For Concern Over Microchip Technology Incorporated's (NASDAQ:MCHP) Price
Jul 15We Think Microchip Technology (NASDAQ:MCHP) Can Stay On Top Of Its Debt
Jun 04Microchip Technology: A Bottom Is Near
May 29Microchip Technology Incorporated (NASDAQ:MCHP) Just Reported And Analysts Have Been Cutting Their Estimates
May 08Microchip Technology (NASDAQ:MCHP) Could Become A Multi-Bagger
Apr 28Here's Why We Think Microchip Technology (NASDAQ:MCHP) Might Deserve Your Attention Today
Apr 16A Look At The Intrinsic Value Of Microchip Technology Incorporated (NASDAQ:MCHP)
Apr 04Some Confidence Is Lacking In Microchip Technology Incorporated's (NASDAQ:MCHP) P/E
Mar 23Microchip: Bullish Stock Price On Analog Market Recovery
Mar 16Should You Think About Buying Microchip Technology Incorporated (NASDAQ:MCHP) Now?
Feb 29Microchip Technology's (NASDAQ:MCHP) Dividend Will Be Increased To $0.45
Feb 15Microchip Technology: Revenue Continues To Decline As Inventory Destocking Persists
Feb 12Analysts Just Shaved Their Microchip Technology Incorporated (NASDAQ:MCHP) Forecasts Dramatically
Feb 06Microchip: Still Digesting An Inventory Build Up
Feb 06Is Microchip Technology (NASDAQ:MCHP) A Risky Investment?
Jan 29Why The 26% Return On Capital At Microchip Technology (NASDAQ:MCHP) Should Have Your Attention
Jan 15A Look At The Fair Value Of Microchip Technology Incorporated (NASDAQ:MCHP)
Dec 17Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
3/31/2027 | 6,562 | 1,634 | 2,215 | 2,369 | 13 |
3/31/2026 | 5,397 | 784 | 1,736 | 1,757 | 23 |
3/31/2025 | 4,574 | 203 | 1,163 | 1,129 | 23 |
9/30/2024 | 5,497 | 782 | 1,511 | 1,704 | N/A |
6/30/2024 | 6,587 | 1,370 | 2,030 | 2,277 | N/A |
3/31/2024 | 7,634 | 1,907 | 2,608 | 2,893 | N/A |
12/31/2023 | 8,541 | 2,356 | 2,815 | 3,172 | N/A |
9/30/2023 | 8,945 | 2,517 | 3,157 | 3,597 | N/A |
6/30/2023 | 8,764 | 2,397 | 3,298 | 3,774 | N/A |
3/31/2023 | 8,439 | 2,238 | 3,135 | 3,621 | N/A |
12/31/2022 | 8,050 | 2,072 | 3,171 | 3,659 | N/A |
9/30/2022 | 7,639 | 1,844 | 2,797 | 3,235 | N/A |
6/30/2022 | 7,215 | 1,540 | 2,648 | 3,053 | N/A |
3/31/2022 | 6,821 | 1,286 | 2,473 | 2,843 | N/A |
12/31/2021 | 6,444 | 964 | 2,233 | 2,544 | N/A |
9/30/2021 | 6,038 | 647 | 1,959 | 2,201 | N/A |
6/30/2021 | 5,698 | 479 | 1,875 | 2,045 | N/A |
3/31/2021 | 5,438 | 349 | 1,824 | 1,917 | N/A |
12/31/2020 | 5,298 | 333 | 1,790 | 1,839 | N/A |
9/30/2020 | 5,233 | 608 | 1,683 | 1,725 | N/A |
6/30/2020 | 5,261 | 644 | 1,612 | 1,665 | N/A |
3/31/2020 | 5,274 | 571 | 1,476 | 1,544 | N/A |
12/31/2019 | 5,278 | 645 | 1,480 | 1,576 | N/A |
9/30/2019 | 5,365 | 384 | 1,552 | 1,662 | N/A |
6/30/2019 | 5,460 | 371 | 1,590 | 1,753 | N/A |
3/31/2019 | 5,350 | 356 | 1,446 | 1,675 | N/A |
12/31/2018 | 5,022 | 328 | 1,384 | 1,631 | N/A |
9/30/2018 | 4,641 | 28 | 1,228 | 1,514 | N/A |
6/30/2018 | 4,221 | 121 | N/A | 1,377 | N/A |
3/31/2018 | 3,981 | 255 | N/A | 1,420 | N/A |
12/31/2017 | 3,881 | 246 | N/A | 1,383 | N/A |
9/30/2017 | 3,721 | 604 | N/A | 1,309 | N/A |
6/30/2017 | 3,580 | 450 | N/A | 1,181 | N/A |
3/31/2017 | 3,408 | 171 | N/A | 1,060 | N/A |
12/31/2016 | 3,063 | 101 | N/A | 939 | N/A |
9/30/2016 | 2,769 | 55 | N/A | 859 | N/A |
6/30/2016 | 2,439 | 84 | N/A | 787 | N/A |
3/31/2016 | 2,173 | 324 | N/A | 744 | N/A |
12/31/2015 | 2,159 | 356 | N/A | 720 | N/A |
9/30/2015 | 2,147 | 381 | N/A | 695 | N/A |
6/30/2015 | 2,152 | 410 | N/A | 737 | N/A |
3/31/2015 | 2,147 | 369 | N/A | 721 | N/A |
12/31/2014 | 2,097 | 381 | N/A | 746 | N/A |
9/30/2014 | 2,051 | 400 | N/A | 709 | N/A |
6/30/2014 | 1,997 | 407 | N/A | 675 | N/A |
3/31/2014 | 1,931 | 395 | N/A | 677 | N/A |
12/31/2013 | 1,868 | 343 | N/A | 601 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (31% al año) de MCHP es superior a la tasa de ahorro (2.6%).
Beneficios vs. Mercado: Se prevé que los beneficios (31% al año) de MCHP crezcan más rápidamente que el mercado US (15.4% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de MCHP crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (10.6% al año) de MCHP crezcan más rápidamente que los del mercado US (8.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 10.6% al año) de MCHP crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de MCHP sea alta dentro de 3 años (30.3%)